Literature DB >> 7378315

Interaction between the glucose-6-phosphate dehydrogenase deficiency and thalassaemia genes at phenotype level.

G Sanna, F Frau, M A Melis, R Galanello, S De Virgiliis, A Cao.   

Abstract

No significant differences were observed in the mean values of Hb A2 levels and red cell indices between G6PD- and G6PD+ beta thalassaemia carriers apart from the MCV, which was significantly higher in beta thalassaemia G6PD- subjects, but still in the thalassaemia carrier range. No difference was seen between G6PD+ and G6PD- alpha thalassaemia carriers. G6PD+ beta thalassaemia carriers show a significant increase in G6PD levels expressed as activity per g of Hb and to lesser extent as activity per number of red cells x 10(9); in G6PD+ alpha thalassaemia carriers this increase is statistically significant only when the enzyme levels are expressed as activity per g of Hb. G6PD- beta thalassaemia carriers had enzyme levels higher than non-thalassaemic G6PD- subjects only when the activity is expressed per g of Hb. G6PD activity was found to be increased in G6PD+ and G6PD- Hb H disease patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378315     DOI: 10.1111/j.1365-2141.1980.tb08709.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.

Authors: 
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 2.  Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.

Authors:  Bridget S Penman; Sunetra Gupta; David J Weatherall
Journal:  Br J Haematol       Date:  2014-12-17       Impact factor: 6.998

3.  The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.

Authors:  Germana Bancone; Michael Kalnoky; Cindy S Chu; Nongnud Chowwiwat; Maria Kahn; Benoit Malleret; Pornpimon Wilaisrisak; Laurent Rénia; Gonzalo J Domingo; Francois Nosten
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.